Skip to main content
Home
  • Get Updates
  • Members and Providers
    • Member
    • Provider
      • Who We Serve: Overview
      • Consultants
      • Employers
      • Federal
      • Health Plans
      • Hospitals and Health Systems
      • Labor Unions
      • Public Sector
      • Members
      • Providers
      • Health Plans
      • Employers
      • Consultants
      • Labor Unions
      • Federal
      • Public Sector
      • Hospitals & Health Systems
      • Providers
      • Lower Costs
      • Improve Outcomes
      • Expand Access
      • Increase Member Engagement
      • Musculoskeletal
      • Behavioral Health
      • Oncology
      • Cardiovascular Disease
      • Diabetes
      • Obesity
      • Women’s Health and Family Planning
      • Pharmacy
      • Specialty
      • Express Scripts by Evernorth
      • Express Scripts Pharmacy by Evernorth
      • Accredo by Evernorth
      • EviCore by Evernorth
      • CuraScript SD by Evernorth
      • MyMatrixx by Evernorth
      • Freedom Fertility by Evernorth
      • MD Live by Evernorth
      • Insights
      • Newsroom
      • Behavioral Health
      • Gene Therapy
      • GLP-1s
      • Health Equity
      • Oncology
      • Women's Health
      • Health Care in Focus
      • Importance of Vitality
      • Pharmacy in Focus
      • Women's Health Report
      • Youth Mental Health
      • Evernorth Research Institute
      • The Lab by Evernorth
    • Why Evernorth?
    • About Us
    • Careers
  • Get Updates
  • Members and Providers
    • Member
    • Provider
Close search filters
info
Changing filters will change the listed Success Criteria and Techniques

Category
  • All Results
  • (-) article (343)
  • expert (75)
  • event (1)
  • topic pages (7)
  • page (173)
  • report (15)

Topic
  • Accredo
  • CuraSciptSD
  • eviCore
  • Express Scripts PBM
  • Express Scripts Pharmacy
  • Freedom Fertility
  • Inside Rx
  • MDLIVE

Search results (343)
Filter By
Article
Normalizing postpartum depression
June 02, 2023
A robust education and treatment plan are key to helping those who suffer from one of the most common pregnancy complications.
Read more
Article
Three of the biggest drivers of health care costs
June 07, 2023
Obesity, diabetes, and cardiovascular disease are on the rise. Left unmanaged, these comorbid conditions can cause medical expenses to skyrocket and lead to poor health outcomes, inclusive of disabili...
Read more
Article
One in four adults diagnosed with ADHD don’t get treatment
June 26, 2023
Our study, which is based on 495,180 adults with diagnosed ADHD, uncovered that social and economic factors impact the prevalence of ADHD treatment.
Read more
Article
Meet Dr. Eric Weil, chief medical officer of MDLIVE
July 07, 2023
Dr. Eric Weil, chief medical officer of MDLIVE by Evernorth, has been able to blend his dream of being a doctor with his passion for health care innovation, helping to bring quality health care to mil...
Read more
Article
Express Scripts takes steps to protect Medicare Part D
June 13, 2023
We believe robust pharmacy networks are critical to ensuring access for Medicare customers and that individual pharmacists deserve the opportunity to make the decision that’s best for their business.
Read more
Article
Post-miscarriage depression can impact whole-family health if left untreated
July 25, 2023
Losing a pregnancy can have traumatic psychological impacts on women. When left untreated, they can have detrimental and long-lasting effects on the health and well-being of these women and their fami...
Read more
Article
In case you missed it: Key behavioral care insights from AHIP 2023
June 27, 2023
Among the key takeaways from the AHIP 2023 conference: The health care system must do a better job of working together to provide people with the right behavioral health care resources at the right ti...
Read more
Article
The facts about home delivery
August 02, 2023
A behind-the-scenes look at how Express Scripts Pharmacy by Evernorth gets medication from our door to yours.
Read more
Article
Helping members navigate postpartum care
June 28, 2023
Plan sponsors should be aware of the important health implications the “fourth trimester” of pregnancy holds for new mothers.
Read more
Article
Leveraging biosimilars to drive savings and support patient access
July 01, 2024
By the end of 2024, 3 FDA-approved biosimilars to Stelara for patients living with inflammatory conditions will be closer to launch, enabling lower total drug spend.
Read more
  • Load More
Home

Footer Column 1

  • Solutions
  • News and Insights
  • Press Releases
  • Careers
  • About Us
  • Accreditation
  • Contact Us

Footer Column 2

  • Express Scripts by Evernorth
  • Express Scripts Pharmacy by Evernorth
  • Accredo by Evernorth
  • Freedom Fertility by Evernorth
  • EviCore by Evernorth
  • MyMatrixx by Evernorth

Footer Column 3

  • CuraScript SD by Evernorth
  • Evernorth Behavioral Care Group
  • Evernorth Care Group
  • Inside Rx
  • MD Live by Evernorth
Facebook Logo Instagram Logo Linkedin Logo YouTube Logo

 

Language Assistance

Español [PDF]  |  中文 [PDF]  |  Tiếng Việt [PDF]  |  한국어 [PDF]  |  Tagalog [PDF]  |  Русский [PDF]   |  العربية [PDF]  |  Kreyòl [PDF]

Français [PDF]  |  Português [PDF]  |  Polski [PDF]  |  日本語 [PDF]  |  Italiano [PDF]  |  Deutsch [PDF]  |  فارسی [PDF]  |  More… [PDF]

 

Availability of programs and services may vary by location and is subject to change.

© 2025 Evernorth Health, Inc. All rights reserved. One Express Way, St. Louis, MO 63121
All products and services are provided by or through operating subsidiaries or affiliates of Evernorth.

 

Terms of Use Privacy Notice Notice of Privacy Practices

Accessibility   Health Care Fraud   Nondiscrimination Notice    WA Consumer Health Data Privacy Notice

View all Evernorth Privacy Notices